Antiplatelet Resumption after Antiplatelet-Related Intracerebral Hemorrhage: A Retrospective Hospital-Based Study-Reference-Cited by-同舟云学术

Antiplatelet Resumption after Antiplatelet-Related Intracerebral Hemorrhage: A Retrospective Hospital-Based Study

Published:2017-10 Issue: Volume:106 Page:85-91
ISSN:1878-8750
Container-title:World Neurosurgery
language:en
Short-container-title:World Neurosurgery

Author:

Teo Kay-Cheong,Lau Gary K.K.,Mak Ryan H.Y.,Leung Ho-Yan,Chang Richard S.K.,Tse Man-Yu,Lee Raymand,Leung Gilberto K.K.,Ho Shu-Leong,Cheung Raymond T.F.,Siu David C.W.,Chan Koon-Ho

Publisher

Elsevier BV

Subject

Neurology (clinical),Surgery

Reference41 articles.

1. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials;Baigent;Lancet,2009

2. Risk of hemorrhagic stroke with aspirin use: an update;Gorelick;Stroke,2005

3. Long-term mortality after intracerebral hemorrhage;Flaherty;Neurology,2006

4. Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death;Saloheimo;Stroke,2006

5. Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry;Sacco;Stroke,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial and ethnic differences in restarting antiplatelet therapy in patients with primary intracranial hemorrhage: a systematic review and meta-analysis;BMC Neurology;2024-08-10

2. Antiplatelet Agent Use After Stroke due to Intracerebral Hemorrhage;Stroke;2023-12

3. Ischemic Stroke Prevention After Intracerebral Hemorrhage;Current Treatment Options in Cardiovascular Medicine;2023-06-26

4. Blood Pressure Control Targets and Risk of Cardiovascular and Cerebrovascular Events After Intracerebral Hemorrhage;Stroke;2023-01

5. Early-start antiplatelet therapy after operation in patients with spontaneous intracerebral hemorrhage and high risk of ischemic events (E-start): Protocol for a multi-centered, prospective, open-label, blinded endpoint randomized controlled trial;Frontiers in Aging Neuroscience;2022-11-23